SNUH MICU Cohort Study of PICS
Sponsor
Seoul National University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03216785
Collaborator
(none)
5,000
1
120
41.7
Study Details
Study Description
Brief Summary
Prospective registry of patients admitted to the medical intensive care unit Patients discharged are followed up to 5 years after discharge
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
5000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Cohort Study of Patients Patients in the Medical Intensive Care Unit to Evaluate Postintensive Care Sydnrome
Actual Study Start Date
:
Jul 1, 2017
Anticipated Primary Completion Date
:
Jul 1, 2027
Anticipated Study Completion Date
:
Jul 1, 2027
Outcome Measures
Primary Outcome Measures
- Functional status [3 month]
Clinical frailty scale, The de Morton Mobility Index
Secondary Outcome Measures
- Survival [1 year]
Survival
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patients admitted to the medical intensive care unit
Exclusion Criteria:
-
Patients admitted to the intensive care unit for simple procedures
-
Patients admitted for postoperative care observation
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Seoul National University Hospital | Seoul | Korea, Republic of | 110744 |
Sponsors and Collaborators
- Seoul National University Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Jinwoo Lee,
Assistant Professor,
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT03216785
Other Study ID Numbers:
- 1704140848
First Posted:
Jul 13, 2017
Last Update Posted:
Aug 20, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No